Skip to main content
Tony Nickonchuk

Tony Nickonchuk

Clinical Evidence Expert at The College of Family Physicians of Canada; clinical pharmacist specializing in drug utilization and cardiovascular evidence.

Jul 23, 2026

16:54
excellent no that's good and now there's a uh about two or three more things we have there one of the things that comes up again on a somewhat regular basis is that is uh black bladder whether you got a full bladder versus empty now that did make a bit of a difference right tony
17:09
Yeah, this study was actually really interesting.
17:12
It was quite well done.
17:15
And they did a lot to... ensure that really everything else about the condition was equal between the conditions.
17:26
So this was 172 women.
17:27
It was just women.
17:29
And they actually ensured that they had an ultrasound confirmed full bladder.

9 MINS LATER

26:20
Now you also sort of gave some, Antonio, maybe you want to comment on this, that the, you know, a five millimeter reduction in systolic blood pressure, what actually that means from a cardiovascular event perspective?
8:14
just to put in, so if you look at the pure definition, you would say that this is primary prevention, but there is a huge but here.
8:24
Yeah, there's a huge but, and what do they say? Nothing matters before the but.
8:32
So they had coronary artery disease, cerebrovascular artery disease, or peripheral artery disease.
8:40
And there was all sorts of examples they gave of what qualified for those three diseases in terms of their classification.
8:49
So someone who had a prior coronary revascularization would be included.
8:54
Someone who had a TIA would be included.
8:59
Someone with significant peripheral vascular disease would be included.
10:25
So that does make a difference.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.